Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain drain: walking and thinking at once trips up Parkinson's patients

NCT ID NCT07584343

Knowledge-focused Sponsor: University of Cadiz Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how leg muscles work in people with Parkinson's disease when they walk forward and backward while also doing a mental task. Researchers compared 30 Parkinson's patients to healthy people of similar age. The goal was to understand why multitasking while walking increases fall risk, but no treatment or cure was tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

30 people

The number who actually took part.

Started

Mar 2026

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with Parkinson's disease and mild cognitive and gait functional impairment recruited from the Parkinson's Association of Seville.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Ability to walk independently for at least 5 meters, both forward and backward, without the need for assistive devices or assistance from another person. * Diagnosis of idiopathic Parkinson's disease made by a neurologist at Hospital Virgen Macarena. * Hoehn and Yahr stage I-III. * Being in the "ON" phase of antiparkinsonian medication during the assessment (approximately one hour after intake, when the pharmacokinetic curve of levodopa reaches its peak). Exclusion Criteria: * Presence of symptomatic musculoskeletal disorders affecting the lower limbs (LL) (relevant orthopedic surgery or leg length discrepancy \> 1 cm), or other neurological conditions (stroke, neuropathies, etc.) that independently affect gait. * Balance disorders due to other causes (vestibulopathy, severe orthostatic hypotension, etc.). * Decompensated systemic diseases (cardiac disease, COPD, uncontrolled diabetes mellitus, etc.). * Uncorrected visual impairments that may affect gait performance. * Previous treatment with deep brain stimulation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dual-task walking are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Gait Disorders, Neurologic Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dual-task walking Electromyography Parkinson disease (PD)

Contacts and locations

Locations

  • Sevilla, España

    Seville, Sevilla, 41015, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.